Literature DB >> 8785893

Cyclosporine: what clinicians need to know.

J Koo1, J Lee.   

Abstract

Cyclosporine is known to be highly efficacious for the treatment of psoriasis as well as several other dermatologic conditions. Because of its profound anti-inflammatory properties and a side-effect profile that differs from other agents, such as methotrexate, the availability of cyclosporine confers certain advantages in meeting the challenges of treating recalcitrant psoriasis. In short-term use, cyclosporine can induce dramatic improvements in psoriasis, especially patients who present with intense inflammation. Because of nephrotoxicity and the possible development of hypertension, however, its utility in long-term usage, especially continuous usage beyond 1 year, is still to be defined. With contemporary attempts to use combination and rotational therapies to maximize therapeutic efficacy and minimize risk of long-term side effects, cyclosporine is definitely a welcome addition to our current armamentarium in the treatment of psoriasis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785893

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  4 in total

1.  Pharmacokinetics of oral fumarates in healthy subjects.

Authors:  Nicolle H R Litjens; Jacobus Burggraaf; Elisabeth van Strijen; Co van Gulpen; Herman Mattie; Rik C Schoemaker; Jaap T van Dissel; H Bing Thio; Peter H Nibbering
Journal:  Br J Clin Pharmacol       Date:  2004-10       Impact factor: 4.335

Review 2.  Comparative tolerability of systemic treatments for plaque-type psoriasis.

Authors:  Stacy L McClure; Jayme Valentine; Kenneth B Gordon
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 3.  Recognition and treatment of psoriasis. Special considerations in elderly patients.

Authors:  C Bonifati; M Carducci; A Mussi; L D'Auria; F Ameglio
Journal:  Drugs Aging       Date:  1998-03       Impact factor: 3.923

4.  In vitro pharmacokinetics of anti-psoriatic fumaric acid esters.

Authors:  Nicolle H R Litjens; Elisabeth van Strijen; Co van Gulpen; Herman Mattie; Jaap T van Dissel; H Bing Thio; Peter H Nibbering
Journal:  BMC Pharmacol       Date:  2004-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.